Forecast & Rating8 analysts currently cover Astria Therapeutics, with about 12.5% giving a positive rating — meaning they expect the stock to rise. The average price target is $24.60, about 95.5% upside from the current price of $12.58. Price targets range from $13.00 to $49.00 — a wide spread, showing clear disagreement over just how much Astria Therapeutics can rise. For you, this means most institutions are cautious on Astria Therapeutics's outlook. Data as of Jan 23, 2026; for reference only and not investment advice.
Nov 12, 2025Price forecast
$24.6095.55%
Forecast & RatingHold
8analysts
- Strong buy12.50%
- Buy0.00%
- Hold87.50%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met0.0%
Stock price$12.58
Avg. target$24.6
High target$49
Low target$13
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.